KORU Medical Systems, Inc. (KRMD)
NASDAQ: KRMD · Real-Time Price · USD
4.020
+0.320 (8.65%)
Dec 20, 2024, 4:00 PM EST - Market closed
KORU Medical Systems Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 31.99 | 28.52 | 27.9 | 23.49 | 24.18 | 23.16 | Upgrade
|
| Revenue Growth (YoY) | 11.57% | 2.23% | 18.76% | -2.84% | 4.38% | 33.47% | Upgrade
|
| Cost of Revenue | 11.89 | 11.81 | 12.53 | 9.72 | 9.24 | 8.31 | Upgrade
|
| Gross Profit | 20.1 | 16.71 | 15.37 | 13.77 | 14.94 | 14.85 | Upgrade
|
| Selling, General & Admin | 20.82 | 20.37 | 20.61 | 17.86 | 12.03 | 9.77 | Upgrade
|
| Research & Development | 5.43 | 5.74 | 4.96 | 2.47 | 1.3 | 0.74 | Upgrade
|
| Operating Expenses | 27.15 | 26.98 | 26.15 | 20.8 | 13.74 | 10.85 | Upgrade
|
| Operating Income | -7.05 | -10.27 | -10.78 | -7.03 | 1.19 | 4 | Upgrade
|
| Interest & Investment Income | 0.53 | 0.56 | 0.15 | 0.01 | 0.04 | 0.08 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.01 | -0.01 | -0.04 | -0.03 | 0 | -0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | - | - | 0.68 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -6.53 | -9.71 | -10.68 | -6.37 | 1.24 | 4.06 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0 | -0.06 | - | 0 | 0.02 | 0.05 | Upgrade
|
| Legal Settlements | - | - | - | - | -2.45 | -3.42 | Upgrade
|
| Pretax Income | -6.53 | -9.77 | -10.68 | -6.36 | -1.19 | 0.7 | Upgrade
|
| Income Tax Expense | 5.45 | 3.97 | -2.01 | -1.8 | 0.02 | 0.13 | Upgrade
|
| Net Income | -11.97 | -13.74 | -8.66 | -4.56 | -1.21 | 0.56 | Upgrade
|
| Net Income to Common | -11.97 | -13.74 | -8.66 | -4.56 | -1.21 | 0.56 | Upgrade
|
| Net Income Growth | - | - | - | - | - | -38.02% | Upgrade
|
| Shares Outstanding (Basic) | 46 | 46 | 45 | 44 | 42 | 39 | Upgrade
|
| Shares Outstanding (Diluted) | 46 | 46 | 45 | 44 | 42 | 39 | Upgrade
|
| Shares Change (YoY) | 0.51% | 1.33% | 1.39% | 5.86% | 7.34% | 0.36% | Upgrade
|
| EPS (Basic) | -0.26 | -0.30 | -0.19 | -0.10 | -0.03 | 0.01 | Upgrade
|
| EPS (Diluted) | -0.26 | -0.30 | -0.19 | -0.10 | -0.03 | 0.01 | Upgrade
|
| EPS Growth | - | - | - | - | - | -50.00% | Upgrade
|
| Free Cash Flow | -1.7 | -5.68 | -8.17 | -4.67 | -1.66 | 0.12 | Upgrade
|
| Free Cash Flow Per Share | -0.04 | -0.12 | -0.18 | -0.11 | -0.04 | 0.00 | Upgrade
|
| Gross Margin | 62.82% | 58.59% | 55.09% | 58.62% | 61.78% | 64.13% | Upgrade
|
| Operating Margin | -22.05% | -36.01% | -38.65% | -29.93% | 4.93% | 17.28% | Upgrade
|
| Profit Margin | -37.42% | -48.18% | -31.05% | -19.42% | -5.01% | 2.44% | Upgrade
|
| Free Cash Flow Margin | -5.31% | -19.90% | -29.27% | -19.86% | -6.88% | 0.52% | Upgrade
|
| EBITDA | -6.15 | -9.4 | -10.19 | -6.57 | 1.61 | 4.34 | Upgrade
|
| EBITDA Margin | -19.22% | -32.96% | -36.54% | -27.95% | 6.66% | 18.74% | Upgrade
|
| D&A For EBITDA | 0.91 | 0.87 | 0.59 | 0.46 | 0.42 | 0.34 | Upgrade
|
| EBIT | -7.05 | -10.27 | -10.78 | -7.03 | 1.19 | 4 | Upgrade
|
| EBIT Margin | -22.05% | -36.01% | -38.65% | -29.93% | 4.93% | 17.27% | Upgrade
|
| Effective Tax Rate | - | - | - | - | - | 18.96% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.